DMPI
DelMar Pharmaceuticals, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Market Cap: 15.3 Million
Primary Exchange: NASDAQ
Website: http://www.delmarpharma.com
Shares Outstanding: 11.5 Million
Float: 11.3 Million
Dividend: (%)
Beta: 0.7383002951724373
Sector: Distribution Services
Industry: Wholesale Distributors
Ethical Flags
Longest drawdown: 2700 trading days
From: 2013-02-27 To: 2020-08-19
Lowest Point:
Delmar Pharma updates terms of rights offering
via: SeekingAlpha at 2019-06-11 03:40:23:000
DelMar Pharmaceuticals (NASDAQ: DMPI ) has adjusted certain pricing information and key dates for its previous rights offering. The subscription period will now expire at 5:00 PM ET on June 25, unless extended by the Company. More news on: DelMar Pharmaceuticals, Inc., Healthcare s… read more...
Delmar Pharma updates terms of rights offering
via: SeekingAlpha at 2019-06-11 03:40:23:000
DelMar Pharmaceuticals (NASDAQ: DMPI ) has adjusted certain pricing information and key dates for its previous rights offering. The subscription period will now expire at 5:00 PM ET on June 25, unless extended by the Company. More news on: DelMar Pharmaceuticals, Inc., Healthcare s… read more...
Delmar Pharma updates terms of rights offering
via: SeekingAlpha at 2019-06-11 03:40:23:000
DelMar Pharmaceuticals (NASDAQ: DMPI ) has adjusted certain pricing information and key dates for its previous rights offering. The subscription period will now expire at 5:00 PM ET on June 25, unless extended by the Company. More news on: DelMar Pharmaceuticals, Inc., Healthcare s… read more...
Delmar Pharmaceuticals Updates The Terms Of Previously Announced Rights Offering
via: PR Newswire at 2019-06-11 01:30:00:000
VANCOUVER, British Columbia and MENLO PARK, Calif. , June 11, 2019 /PRNewswire/ --DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it … read more...
Delmar Pharmaceuticals Updates The Terms Of Previously Announced Rights Offering
via: PR Newswire at 2019-06-11 01:30:00:000
VANCOUVER, British Columbia and MENLO PARK, Calif. , June 11, 2019 /PRNewswire/ --DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it … read more...
Delmar Pharmaceuticals Updates The Terms Of Previously Announced Rights Offering
via: PR Newswire at 2019-06-11 01:30:00:000
VANCOUVER, British Columbia and MENLO PARK, Calif. , June 11, 2019 /PRNewswire/ --DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-05-20 | 4.0 | 1.0 | 4.0 |